Third Xiangya Hospital of Central South University
Changsha, Hunan, 410013, China
NCT Number: NCT07612124
The goal of this clinical trial is to evaluate the value of a smart application named "Weiyin Health" in the follow-up management of patients undergoing peritoneal dialysis. The main questions it aims to answer are:
Can the use of a smart application reduce the unplanned readmission rate?
Can the use of a smart application reduce the incidence of peritonitis?
Researchers will compare patients who use the smart application for follow-up with those who receive conventional follow-up.
Eligible patients on peritoneal dialysis will be randomly assigned to one of two groups: one group will receive conventional follow-up (WeChat group + telephone reminders), and the other group will use the "Weiyin Health" smart application for follow-up (including data collection, AI-based Q&A, follow-up reminders, and risk alerts). Both groups will attend peritoneal dialysis specialty clinic visits once every 3 months for routine check-ups over a 12-month period.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Changsha, Hunan, 410013, China
Study Design:
This is a prospective, randomized, controlled, open-label study. Eligible patients on peritoneal dialysis will be randomized in a 1:1 ratio to either the conventional follow-up group or the smart application follow-up group. A total of 800 participants are planned for enrollment.
Eligibility Criteria:
Inclusion criteria
Exclusion criteria
Interventions:
Conventional Follow-up Group:
Smart Application Follow-up Group:
Data collection AI-based one-on-one Q&A Follow-up reminders Risk alerts
Common Interventions (Both Groups):
All patients in both groups will attend routine peritoneal dialysis specialty clinic follow-up visits once every 3 months for 12 consecutive months. Follow-up include:
Outcome Measures:
Primary Outcome Measures:
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Participants receive conventional follow-up care including a WeChat group for peritoneal dialysis health education and Q&A, and telephone reminders for follow-up visits.
A smart application installed on participants' mobile devices that provides functions including data collection, AI-based one-on-one Q&A, follow-up reminders, and risk alerts for peritoneal dialysis patients.
Other names: Weiyin Health APP
Time frame: 12 months
The proportion of participants who experience unplanned hospital readmission during the 12-month follow-up period.
Time frame: 12 months
The proportion of participants who develop peritonitis during the 12-month follow-up period. Peritonitis is defined according to the International Society for Peritoneal Dialysis (ISPD) criteria.
The Third Xiangya Hospital of Central South University
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02147977
Arrhythmias Cardiac, Arrhythmias, Cardiac
Aalborg, Denmark
View Trial DetailsNCT07730385
Cardiovascular Disease, Cardiovascular Diseases
Vienna, State of Vienna, Austria
View Trial DetailsNCT07544797
Chronic Disease, Disease Attributes
Halle, Saxony-Anhalt, Germany
View Trial DetailsNCT06910475
Behavior, Chronic Disease
Taguatinga, Federal District, Brazil
View Trial Details